drug protocol number

CHRC2019

drug sponsor

Canadian Heart Research Centre

drug study

any SFDA registered anti-hyperlipidemic product

drug trial site

King Fahd Armed Forces Hospital (Jeddah), King Fahd Military Medical Complex (Dhahran), King Abdullah Medical Complex (Jeddah), King Fahad Hospital (Jeddah), King Fahad Genaral Hospital (Medina), King Khaled General Hospital (Hafar Al Batin), Royal Commission Hospital Jubail

drug status

Ongoing

drug phase